Clinical trial
Early Inhaled Nitric Oxide for Respiratory Failure in Newborns
NCT00005773 · NICHD Neonatal Research Network, Other · Terminated
Key facts
| NCT number | NCT00005773 |
|---|---|
| Title | Early Inhaled Nitric Oxide for Respiratory Failure in Newborns |
| Official title | Early Inhaled Nitric Oxide Therapy in Term and Near Term Infants With Respiratory Failure |
| Acronym | Early iNO |
| Lead sponsor | NICHD Neonatal Research Network, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH Canadian Institutes of Health Research (CIHR) Mallinckrodt Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infant, Newborn, Hypertension, Pulmonary, Persistent Fetal Circulation Syndrome, Pneumonia, Aspiration, Respiratory Distress Syndrome, Respiratory Insufficiency |
| Intervention type | Drug |
| Interventions | Inhaled Nitric Oxide, Standard iNO therapy |
| Enrollment | 302 |
| Start date | Aug 1, 1998 |
| Primary completion | May 1, 2001 |
| Completion | Aug 1, 2003 |
| First posted | Jun 2, 2000 |
| Last update posted | Sep 26, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: